BioSpace News Archive

Acerus Enters into Loan Facility to Support Anticipated Product Launch and Sales and Marketing Initiatives

Acerus Pharmaceuticals today reported that it has entered into a senior secured term credit facility with Quantius for up to Cdn. $5 million.

December 6, 2017

·

4 min read

Drug Development

PaxVax’s Randomized Placebo-Controlled Study Provides Encouraging Results for a Higher Dose Formulation of Vaxchora (CVD 103-HgR) as a Potential Tool in Containing Cholera Epidemics

Results support potential future development of a new formulation of Vaxchora as an important additional tool for global cholera control in developing countries.

December 6, 2017

·

6 min read

Biotech Beach

Biocept Announces Pricing of Public Offering of up to 4,925,936 Shares of Common Stock

No warrants to purchase shares of the Company’s common stock will be issued to the investors in connection with the offering.

December 6, 2017

·

4 min read

Business

Charles River Adds ERS License to CRISPR/Cas9 Service Offering

The license, coupled with the existing license through the Broad Institute of MIT and Harvard, allows Charles River to offer custom in vivo and in vitro genome editing.

December 6, 2017

·

2 min read

Next-Generation High-Definition Visualization System for Minimally Invasive Surgery Introduced by DePuy Synthes

Today, the PUREVUE Visualization System was unveiled at the Orthopaedic Summit 2017.

December 6, 2017

·

2 min read

Drug Development

Sirnaomics’ Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma

The product has also received both US FDA and Chinese FDA IND approval for Hypertrophic Scar Reduction and it is expected to have efficacy in many diseases across multiple therapeutic areas.

December 6, 2017

·

4 min read

Biotech Beach

CytRx Corporation Announces Filing of Key Provisional Patent Applications for Ultra-High Potency LADR Drug Candidates

When granted, these new patents will expand CytRx’s intellectual property estate and the Company will own worldwide rights for each.

December 6, 2017

·

4 min read

Business

Viriom Announces New Director Appointment

Viriom is pleased to announce the appointment of Augustine Lawlor as Director of Viriom.

December 6, 2017

·

2 min read

Drug Development

Nemaura Announces Successful SugarBEAT Interim Precision Study Results

The results indicated that over 80% of all data between the skin-patches at each time point were within 8% of each other, with an average precision of 1.07.

December 6, 2017

·

3 min read

Deals

Medigene Sells U.S.-Rights for Veregen and Raises Financial Guidance 2017

MediGene today announced the sale of the US-rights for its drug Veregen to Fougera Pharma.

December 6, 2017

·

3 min read